Body Handbook Catalogue Profile Ranking
Supplements BODY HANDBOOK
Supplements Β· Β§505
DIM and Indole-3-Carbinol
DIM and indole-3-carbinol are broccoli molecules sold for hormonal acne, heavy periods, breast tenderness, and cancer worry. The molecular effect is real: a few weeks of daily dosing shifts how your liver breaks down estrogen. What no controlled trial has shown is the part you bought it for: fewer breakouts, easier periods, less cancer. The biggest proper trial, in 551 women, found nothing. It is cheap and nearly harmless, so trying it is low-stakes for most people. Except one: on tamoxifen, it weakens the drug.
Do Β· Daily Evidence Mixed Chapter Supplements

What it actually does. Indole-3-carbinol (I3C) is what raw broccoli releases; your stomach acid turns it into DIM, the more potent finished form. Both are sold as supplements, and both do the same job: they nudge your liver to send estrogen down its milder breakdown route instead of the more active one. The shift is measurable and reproducible. Five hundred milligrams of I3C daily moved the mild-route share from about 29% to about 46% in a week 1, and the ratio settles over a few weeks 2.

Then the evidence thins out. The molecule moves the biomarker its inventors cared about. Whether moving that biomarker changes anything you'd feel is a different question, and the clinical record is thin.

A small trial of 30 women with high-grade abnormal Pap smears looked striking: about half the I3C group had their cervical lesions regress, none on placebo 3. It didn't hold. A larger trial of 551 women taking 150 mg of DIM for six months found no difference in progression and identical HPV clearance 4. A separate 60-woman study saw the estrogen ratio rise and a small body-fat drop 5 β€” promising, and untested at scale. For hormonal acne, the reason most people buy it, there is no placebo-controlled trial at all.

If you try it, treat it as a personal experiment. Set an honest before-state to compare against, like a lesion count or a period diary, or the placebo response will fool you.

One quiet catch: after about four weeks your blood levels of DIM drop by roughly half, so more time on it may not keep building results 7.

If the goal is concrete, better tools exist: for hormonal acne, oral contraceptives, spironolactone, and topical retinoids; for real cancer risk, tamoxifen after an oncology assessment. Eating cruciferous vegetables is the food version and carries its own cancer-risk signal 14.

The fine print β€” when to skip it, and what people get wrong

On tamoxifen, don't take it without your oncologist: it lowers endoxifen, the drug's active form 8. Skip it in pregnancy 9. With ER-positive breast cancer history, ask first; at low estrogen DIM can activate the receptor 10. It induces liver CYP enzymes, so interactions with warfarin and the pill are plausible 11.

"It's just concentrated broccoli": no, the trial dose is one to two kilograms of raw crucifers daily 12. "It only blocks estrogen": no, the pharmacology runs both ways 10. The male evidence is one small prostate trial 13.

References
  1. 1Michnovicz JJ, Bradlow HL (1990). Induction of estradiol metabolism by dietary indole-3-carbinol in humans. Journal of the National Cancer Institute. link
  2. 2Michnovicz JJ, Adlercreutz H, Bradlow HL (1997). Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. Journal of the National Cancer Institute. link
  3. 3Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM (2000). Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecologic Oncology. link
  4. 4CastaΓ±on A, Tristram A, Mesher D, Powell N, Beer H, Ashman S, Rieck G, Fielder H, Fiander A, Sasieni P (2012). Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial. British Journal of Cancer. link
  5. 5Hoseini SM, Saidijam M, Yadegarazari R, Shabab N, Asadi S, Najafi R, Khosravi M, Mahmoodi A, Mehdizadeh M, Zamani N (2022). Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women. Nutrition and Cancer. link
  6. 6Reed GA, Sunega JM, Sullivan DK, Gray JC, Mayo MS, Crowell JA, Hurwitz A (2008). Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3'-diindolylmethane in healthy subjects. Cancer Epidemiology, Biomarkers and Prevention. link
  7. 7Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA, Hurwitz A (2006). Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiology, Biomarkers and Prevention. link
  8. 8Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA (2017). A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Research and Treatment. link
  9. 9National Toxicology Program (2017). NTP Technical Report on the Toxicology Studies of Indole-3-carbinol in F344/N Rats and B6C3F1/N Mice. link
  10. 10Marques M, Laflamme L, Benassou I, Cissokho C, Guillemette B, Gaudreau L (2014). Low levels of 3,3'-diindolylmethane activate estrogen receptor Ξ± and induce proliferation of breast cancer cells in the absence of estradiol. BMC Cancer. link
  11. 11Memorial Sloan Kettering Cancer Center (2023). Indole-3-Carbinol β€” Integrative Medicine Herb Information. link
  12. 12Linus Pauling Institute (2024). Indole-3-Carbinol β€” Micronutrient Information Center. link
  13. 13Heath EI, Heilbrun LK, Li J, Vaishampayan U, Harper F, Pemberton P, Sarkar FH (2010). A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'-diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. American Journal of Translational Research. link
  14. 14Higdon JV, Delage B, Williams DE, Dashwood RH (2007). Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological Research. link
Β·
505